Cade's Identification of Lithium for Manic-Depressive Illness-The Prospector Who Found a Gold Nugget
*Mental Health Research Institute, University of Melbourne, Melbourne, AustraliaThe Journal of nervous and mental disease (Impact Factor: 1.69). 12/2012; 200(12):1101-4. DOI: 10.1097/NMD.0b013e318275d3cb
John Cade's identification of lithium as a treatment of manic-depressive illness has been judged as a landmark biomedical advance and as an initiator of modern psychopharmacology. His personal background, interests, character, experiences, and key observational skills are sketched to provide the background and logic for his discovery and to argue against his simple self-description as a clinician administrator. The Cade story illustrates the potential strengths of clinical research whereby the clinician observes "signals," formulates hypotheses and explanations, and then pursues or encourages their validity and application. The suggestion that Cade simply "rediscovered lithium" is rejected.
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.